Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications
- PMID: 21220609
- DOI: 10.1200/JCO.2010.30.2554
Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications
Erratum in
- J Clin Oncol. 2011 May 1;29(13):1798
Abstract
Molecular analyses of leukemic blasts from patients with acute myeloid leukemia (AML) have revealed a striking heterogeneity with regard to the presence of acquired gene mutations and changes in gene and microRNA expression. Multiple submicroscopic genetic alterations with prognostic significance have been discovered. Application of gene- and microRNA profiling has identified genome-wide expression signatures that separate cytogenetic and molecular subsets of patients with AML into previously unrecognized biologic and/or prognostic subgroups. These and similar future findings are likely to have a major impact on the clinical management of AML because many of the identified genetic alterations not only represent independent prognosticators, but also may constitute targets for specific therapeutic intervention. In this report, we review genetic findings in AML and discuss their clinical implications.
Similar articles
-
Prognostic factors in AML in relation to (ab)normal karyotype.Best Pract Res Clin Haematol. 2009 Dec;22(4):523-8. doi: 10.1016/j.beha.2009.07.003. Best Pract Res Clin Haematol. 2009. PMID: 19959103 Review.
-
[Prognostic factors of acute myeloid leukemia].Nihon Rinsho. 2012 Apr;70 Suppl 2:389-93. Nihon Rinsho. 2012. PMID: 23133988 Japanese. No abstract available.
-
Mutational landscape of AML with normal cytogenetics: biological and clinical implications.Blood Rev. 2013 Jan;27(1):13-22. doi: 10.1016/j.blre.2012.11.001. Epub 2012 Dec 20. Blood Rev. 2013. PMID: 23261068 Review.
-
Differential expression of specific microRNA and their targets in acute myeloid leukemia.Am J Hematol. 2010 May;85(5):331-9. doi: 10.1002/ajh.21667. Am J Hematol. 2010. PMID: 20425795
-
Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia.Eur J Haematol. 2009 Aug;83(2):90-8. doi: 10.1111/j.1600-0609.2009.01261.x. Epub 2009 Mar 21. Eur J Haematol. 2009. PMID: 19309322
Cited by
-
Effect of NPM1 and FLT3 mutations on the outcomes of elderly patients with acute myeloid leukemia receiving standard chemotherapy.Clin Lymphoma Myeloma Leuk. 2013 Aug;13(4):435-40. doi: 10.1016/j.clml.2013.02.021. Epub 2013 Jun 10. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23763915 Free PMC article.
-
Targeted Therapy of FLT3 in Treatment of AML-Current Status and Future Directions.J Clin Med. 2014 Dec 15;3(4):1466-89. doi: 10.3390/jcm3041466. J Clin Med. 2014. PMID: 26237612 Free PMC article. Review.
-
New opportunities and new problems for acute myeloid leukemia treatment.Haematologica. 2012 Jun;97(6):796. doi: 10.3324/haematol.2012.070243. Haematologica. 2012. PMID: 22665527 Free PMC article. No abstract available.
-
Preleukemic stem cells: leave it or not?Blood Sci. 2020 Apr 6;2(2):54-58. doi: 10.1097/BS9.0000000000000042. eCollection 2020 Apr. Blood Sci. 2020. PMID: 35402817 Free PMC article. Review.
-
Early recovery of the platelet count after decitabine-based induction chemotherapy is a prognostic marker of superior response in elderly patients with newly diagnosed acute myeloid leukaemia.BMC Cancer. 2018 Dec 19;18(1):1269. doi: 10.1186/s12885-018-5160-5. BMC Cancer. 2018. PMID: 30567513 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
